TEV-53408
TV53408-IMM-10209
Phase 1 small_molecule active
Quick answer
TEV-53408 for Vitiligo is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Vitiligo
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active